Efficacy and Safety of Lurbinectedin (LUR) with Irinotecan (IRI) in a Phase 2 Expansion Cohort of Patients (pts) with Synovial Sarcoma (SS).
JOURNAL OF CLINICAL ONCOLOGY(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined